CAPTRUST Financial Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRWD
AC
SCM
VPM
VCM
CAPTRUST Financial Advisors's IRWD Position: Q1 2026 in Review
CAPTRUST Financial Advisors increased its Ironwood Pharmaceuticals (IRWD) stake by 17% in Q1 2026, buying an estimated $45.5K and bringing the position to 74,930 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #2478.
CAPTRUST Financial Advisors first reported a position in IRWD in Q4 2020 and has held it in 16 quarters since. The position peaked at $340K in Q4 2023. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- CAPTRUST Financial Advisors held 74,930 shares of Ironwood Pharmaceuticals worth $263K as of Q1 2026.
- CAPTRUST Financial Advisors bought 11,108 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $45.5K.
- Ironwood Pharmaceuticals made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #2478 holding.
- CAPTRUST Financial Advisors first reported a position in Ironwood Pharmaceuticals in Q4 2020 and has held it in 16 quarters since.
- CAPTRUST Financial Advisors's Ironwood Pharmaceuticals position peaked at $340K in Q4 2023.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.